FDA warned Stavis Seafoods that it lacked a required check for imported frozen aquaculture salmon fillets, making them adulterated.
What happened
FDA inspected Stavis Seafoods' seafood importer establishment in Boston from February 03, 2026, through February 05, 2026; FDA also cited a prior inspection from June 11 through June 13, 2024. FDA found the firm did not have or implement an affirmative step—a required check—to ensure that frozen aquaculture salmon fillets it imports from a redacted supplier were processed in compliance with the seafood HACCP (Hazard Analysis and Critical Control Point) regulation. FDA said the salmon are adulterated because they may have been prepared, packed, or held under insanitary conditions.
What FDA found
Stavis Seafoods did not have or carry out a required check—an affirmative step—to ensure that the frozen aquaculture salmon fillets it imports were processed in compliance with the seafood HACCP regulation.
21 CFR 123.12(a)(2)(ii)
What FDA wants
FDA tells Stavis Seafoods to respond in writing within 15 working days with the specific corrections and documentation, such as HACCP and importer verification records and records of affirmative steps; if corrections cannot be completed, the firm must explain the delay and when it will correct them. FDA also says it may refuse admission, detain without physical examination, seize product, or enjoin the firm if violations are not promptly corrected.
Who should pay attention
- seafood importers
- companies importing salmon or fishery products
- brands and retailers sourcing imported seafood
This is a summary. Read the original letter on fda.gov.